Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

HAE

Haemonetics Corp

Mar 27 • 04:00PM ET

64.21

Dollar change -0.04
Percentage change -0.06	%

Healthcare • Medical Devices • USA • NYSE

Peers: ABT BDX BAX EW MDT HOLX STE BSX TFX XRAY

| Held by: IJH VTI IWM VB VXF VBK IWO MDY VTWO SCHA

Scroll to Statements

Index	RUT	P/E	25.27	EPS (ttm)	2.54	Insider Own	1.11%	Shs Outstand	50.24M	Perf Week	-0.05%
Market Cap	3.23B	Forward P/E	12.95	EPS next Y	4.96	Insider Trans	0.00%	Shs Float	49.68M	Perf Month	-1.11%
Income	130.06M	PEG	1.96	EPS next Q	1.22	Inst Own	113.57%	Short Float	12.14%	Perf Quarter	-16.80%
Sales	1.37B	P/S	2.35	EPS this Y	14.78%	Inst Trans	1.60%	Short Ratio	6.44	Perf Half Y	-14.94%
Book/sh	18.05	P/B	3.56	EPS next Y	9.05%	ROA	5.50%	Short Interest	6.03M	Perf Year	-21.52%
Cash/sh	6.39	P/C	10.05	EPS next 5Y	12.86%	ROE	14.06%	52W Range	58.80 - 97.97	Perf YTD	-17.76%
Dividend Est.	-	P/FCF	33.63	EPS past 5Y	17.09%	ROI	6.12%	52W High	-34.46%	Beta	0.41
Dividend TTM	-	Quick Ratio	2.55	Sales past 5Y	6.80%	Gross Margin	51.09%	52W Low	9.20%	ATR (14)	2.07
Dividend Ex-Date	-	Current Ratio	3.97	EPS Y/Y TTM	2.55%	Oper. Margin	15.62%	RSI (14)	44.03	Volatility	2.23% 3.22%
Employees	3657	Debt/Eq	1.35	Sales Y/Y TTM	8.14%	Profit Margin	9.47%	Recom	1.45	Target Price	96.40
Option/Short	Yes / Yes	LT Debt/Eq	1.35	EPS Q/Q	21.92%	Payout	0.00%	Rel Volume	0.57	Prev Close	64.25
Sales Surprise	-1.19%	EPS Surprise	1.37%	Sales Q/Q	3.66%	Earnings	Feb 06 BMO	Avg Volume	935.83K	Price	64.21
SMA20	-2.10%	SMA50	-3.44%	SMA200	-16.88%	Trades		Volume	533,211	Change	-0.06%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-07-25	Downgrade	BofA Securities	Neutral → Underperform	$95 → $68
Dec-06-24	Initiated	JP Morgan	Overweight	$116
Nov-08-24	Upgrade	Raymond James	Outperform → Strong Buy	$120
Sep-13-24	Initiated	CL King	Buy	$116
Sep-11-24	Initiated	BofA Securities	Neutral	$85
Sep-10-24	Initiated	BTIG Research	Buy	$112
Jun-12-24	Upgrade	Needham	Hold → Buy	$112
Oct-13-22	Initiated	Mizuho	Buy	$90
Jan-27-22	Downgrade	Needham	Buy → Hold
Dec-15-21	Downgrade	Citigroup	Buy → Neutral	$75 → $59
Aug-17-21	Resumed	Raymond James	Outperform	$75
Jun-17-21	Initiated	Citigroup	Buy	$75
May-14-21	Upgrade	CJS Securities	Market Perform → Market Outperform
Apr-20-21	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Apr-19-21	Downgrade	CJS Securities	Market Outperform → Market Perform
Feb-03-21	Upgrade	Barrington Research	Mkt Perform → Outperform	$140
Jan-21-21	Downgrade	Barrington Research	Outperform → Mkt Perform
Nov-05-20	Upgrade	Barrington Research	Mkt Perform → Outperform	$106
May-06-20	Downgrade	Barrington Research	Outperform → Mkt Perform
Mar-31-20	Upgrade	CJS Securities	Market Perform → Market Outperform

Show Previous Ratings

Mar-27-25 10:35PM	Royce Small-Cap Fund Q4 2024 Commentary (SeekingAlpha)
Mar-20-25 11:30AM	Medtronic (MDT) Up 5.6% Since Last Earnings Report: Can It Continue? (Zacks)
09:03AM	3 Healthcare Stocks Walking a Fine Line (StockStory)
Mar-11-25 05:04AM	Medical Devices & Supplies - Specialty Stocks Q4 In Review: Globus Medical (NYSE:GMED) Vs Peers (StockStory)
Mar-03-25 04:10PM	Haemonetics Announces Executive Leadership Updates (PR Newswire)
04:03AM	Loading…
Feb-28-25 04:03AM	A Look Back at Medical Devices & Supplies - Specialty Stocks Q3 Earnings: STAAR Surgical (NASDAQ:STAA) Vs The Rest Of The Pack (StockStory)
Feb-24-25 06:00AM	Haemonetics to Present at Raymond James 46th Annual Institutional Investors Conference (PR Newswire)
Feb-09-25 08:02AM	Inspire Medical Systems (INSP) To Report Earnings Tomorrow: Here Is What To Expect (StockStory)
Feb-07-25 02:07AM	Haemonetics Corp (HAE) Q3 2025 Earnings Call Highlights: Strong Hospital Growth Amid Plasma ... (GuruFocus.com) -5.79%
Feb-06-25 09:30AM	Haemonetics (HAE) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks) -11.58%
07:40AM	Haemonetics (HAE) Q3 Earnings Meet Estimates (Zacks)
06:39AM	Haemonetics: Fiscal Q3 Earnings Snapshot (Associated Press Finance)
06:37AM	Haemonetics Narrows FY25 Adj. EPS Outlook Range, But Trims Revenue Growth - Update (RTT News)
06:28AM	Haemonetics (NYSE:HAE) Misses Q4 Revenue Estimates (StockStory)
06:00AM	Haemonetics 3rd Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website (PR Newswire)
08:03AM	Loading…
Feb-05-25 08:03AM	Earnings To Watch: Haemonetics (HAE) Reports Q4 Results Tomorrow (StockStory)
07:07AM	Haemonetics Corp (HAE) Q3 2025 Earnings Report Preview: What To Look For (GuruFocus.com)
Jan-24-25 09:40AM	Here's Why Haemonetics (HAE) is a Strong Value Stock (Zacks)
Jan-14-25 06:13AM	Haemonetics Completes Sale of Whole Blood Assets to GVS, S.p.A (PR Newswire)
Jan-08-25 05:03PM	Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2025 Results: February 6, 2025 (PR Newswire)
09:40AM	Why Haemonetics (HAE) is a Top Value Stock for the Long-Term (Zacks)
Jan-06-25 06:00AM	Haemonetics to Present at 43rd Annual J.P. Morgan Healthcare Conference (PR Newswire)
Dec-23-24 09:35AM	Down -11.82% in 4 Weeks, Here's Why You Should You Buy the Dip in Haemonetics (HAE) (Zacks)
Dec-06-24 09:40AM	Are Investors Undervaluing Haemonetics (HAE) Right Now? (Zacks)
Dec-04-24 09:55AM	Wall Street Analysts See a 27.84% Upside in Haemonetics (HAE): Can the Stock Really Move This High? (Zacks)
06:22AM	Haemonetics to offload whole-blood business for up to $67M (MedTech Dive)
Dec-03-24 01:16AM	Haemonetics Announces Sale of Whole Blood Assets to GVS, S.p.A (PR Newswire)
Nov-14-24 05:35AM	Haemonetics to close California facility, lay off 75 people (MedTech Dive)
Nov-12-24 04:12PM	Orchestra BioMed Reports Third Quarter 2024 Financial Results and Provides a Business Update (GlobeNewswire)
09:40AM	Here's Why Haemonetics (HAE) is a Strong Value Stock (Zacks)
09:55AM	Loading…
Nov-11-24 09:55AM	Wall Street Analysts Think Haemonetics (HAE) Could Surge 25.58%: Read This Before Placing a Bet (Zacks)
Nov-07-24 09:30AM	Compared to Estimates, Haemonetics (HAE) Q2 Earnings: A Look at Key Metrics (Zacks) +10.71%
07:25AM	Haemonetics (HAE) Tops Q2 Earnings and Revenue Estimates (Zacks)
06:26AM	Haemonetics: Fiscal Q2 Earnings Snapshot (Associated Press Finance)
06:00AM	Haemonetics 2nd Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website (PR Newswire)
Nov-06-24 09:15AM	Haemonetics (HAE) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures (Zacks)
07:09AM	Haemonetics Corp (HAE) Q2 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Oct-31-24 10:01AM	Haemonetics (HAE) Earnings Expected to Grow: Should You Buy? (Zacks)
Oct-09-24 05:28PM	Haemonetics Corp (HAE) Q1 2025 Earnings Call Highlights: Navigating Growth and Challenges (GuruFocus.com)
Oct-03-24 04:05PM	Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2025 Results: November 7, 2024 (PR Newswire)
Sep-24-24 08:00AM	Aligos Therapeutics Strengthens Senior Leadership Team with the Appointment of Hardean Achneck, MD as Chief Medical Officer (GlobeNewswire)
Sep-20-24 12:54AM	Is Haemonetics Corporation (HAE) an Undervalued Healthcare Stock to Buy in 2025 (Insider Monkey)
Sep-02-24 09:35AM	After Plunging -15.88% in 4 Weeks, Here's Why the Trend Might Reverse for Haemonetics (HAE) (Zacks)
Aug-23-24 09:22AM	Implied Volatility Surging for Haemonetics (HAE) Stock Options (Zacks)
Aug-16-24 09:08AM	Haemonetics (HAE) Set to Launch VASCADE MVP XL in US (Zacks)
06:33AM	Haemonetics Vascade MVP XL vascular closure system enters US market (Medical Device Network)
Aug-15-24 06:30AM	Haemonetics Announces Full Market Release for VASCADE MVP XL Vascular Closure System (PR Newswire)
Aug-12-24 07:47AM	Haemonetics (HAE) Q1 Earnings Miss Estimates, Gross Margin Rises (Zacks)
Aug-09-24 09:40AM	Is Haemonetics (HAE) Stock Undervalued Right Now? (Zacks)
09:35AM	Down -14.6% in 4 Weeks, Here's Why Haemonetics (HAE) Looks Ripe for a Turnaround (Zacks)
Aug-08-24 07:25AM	Haemonetics (HAE) Misses Q1 Earnings Estimates (Zacks) -10.84%
06:25AM	Haemonetics: Fiscal Q1 Earnings Snapshot (Associated Press Finance)
06:00AM	Haemonetics 1st Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website (PR Newswire)
Aug-07-24 09:55AM	Wall Street Analysts See a 30.13% Upside in Haemonetics (HAE): Can the Stock Really Move This High? (Zacks)
09:40AM	Why Haemonetics (HAE) is a Top Value Stock for the Long-Term (Zacks)
Aug-01-24 07:00AM	Sotera Health Appoints Christopher Simon to the Board of Directors (GlobeNewswire)
Jul-30-24 06:00AM	Haemonetics Announces CE Mark Certification for the SavvyWire Pre-Shaped Pressure Guidewire (PR Newswire)
Jul-29-24 10:20AM	Hospital Business Recovery to Aid Haemonetics' (HAE) Q1 Earnings (Zacks)
Jul-16-24 09:45AM	Here's Why Haemonetics (HAE) is a Strong Growth Stock (Zacks)
Jul-12-24 11:38AM	Haemonetics (HAE) Banks on Growing Hospital Arm, New Launches (Zacks)
Jul-10-24 09:55AM	Wall Street Analysts Think Haemonetics (HAE) Could Surge 33.2%: Read This Before Placing a Bet (Zacks)
Jul-08-24 04:05PM	Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2025 Results: August 8, 2024 (PR Newswire)
Jun-27-24 09:35AM	Haemonetics (HAE) Loses -5.16% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks)
Jun-19-24 01:26PM	Haemonetics (HAE) Expands VASCADE Line With New Limited Launch (Zacks)
04:52AM	Haemonetics launches VASCADE MVP XL device for venous closure (Medical Device Network)
Jun-18-24 04:15PM	Haemonetics Launches Limited Market Release for New VASCADE MVP XL Vascular Closure Device (PR Newswire)
Jun-14-24 09:40AM	Haemonetics (HAE) is a Top-Ranked Value Stock: Should You Buy? (Zacks)
Jun-13-24 10:19AM	Haemonetics (HAE) Banks on Growing Plasma Arm, Innovation (Zacks)
Jun-03-24 09:45AM	Why Haemonetics (HAE) is a Top Growth Stock for the Long-Term (Zacks)
May-30-24 02:41AM	Insider Sale: President of Global Hospital at Haemonetics Corp (HAE) Sells Shares (GuruFocus.com)
02:41AM	Insider Sale: EVP and General Counsel Michelle Basil Sells 12,990 Shares of Haemonetics Corp (HAE) (GuruFocus.com)
May-29-24 09:40AM	Here's Why Haemonetics (HAE) is a Strong Value Stock (Zacks)
May-27-24 12:45PM	3 Reasons Why Growth Investors Shouldn't Overlook Haemonetics (HAE) (Zacks)
May-24-24 09:55AM	Wall Street Analysts Believe Haemonetics (HAE) Could Rally 26.58%: Here's is How to Trade (Zacks)
May-23-24 12:00PM	Haemonetics (HAE) Upgraded to Strong Buy: What Does It Mean for the Stock? (Zacks)
06:00AM	Haemonetics Prices Upsized Private Placement of $600 Million Convertible Senior Notes (PR Newswire)
May-22-24 09:13AM	Here's Why You Should Buy Haemonetics (HAE) Stock Now (Zacks)
02:06AM	Insider Sale: EVP Josep Llorens Sells Shares of Haemonetics Corp (HAE) (GuruFocus.com)
May-21-24 04:05PM	Haemonetics Announces Proposed Convertible Senior Notes Offering (PR Newswire)
May-17-24 12:00PM	Haemonetics' (HAE) Hospital & Plasma Segments, Innovation Aid (Zacks)
10:20AM	Haemonetics (HAE) Stock Up 10.9% YTD: Will the Rally Continue? (Zacks)
May-14-24 09:15AM	Haemonetics Corporation (HAE) Hit a 52 Week High, Can the Run Continue? (Zacks)
May-13-24 09:40AM	Why Haemonetics (HAE) is a Top Value Stock for the Long-Term (Zacks)
May-10-24 03:57PM	Haemonetics Corporation (NYSE:HAE) Q4 2024 Earnings Call Transcript (Insider Monkey)
12:41PM	Haemonetics Corp (HAE) Fiscal 2024 Earnings: Aligns with EPS Projections, Reveals Robust ... (GuruFocus.com)
10:53AM	Haemonetics (HAE) Q4 Earnings Top Estimates, Margins Expand (Zacks)
10:37AM	Barrington Research Raises Price Target on Haemonetics to $107 From $105, Keeps Outperform Rating (MT Newswires)
May-09-24 10:55AM	HAE Stock Earnings: Haemonetics Beats EPS, Beats Revenue for Q4 2024 (InvestorPlace)
09:30AM	Haemonetics (HAE) Reports Q4 Earnings: What Key Metrics Have to Say (Zacks)
07:20AM	Haemonetics (HAE) Q4 Earnings and Revenues Top Estimates (Zacks)
06:39AM	Haemonetics' Fiscal Q4 Adjusted Earnings, Revenue Rise (MT Newswires)
06:28AM	Haemonetics: Fiscal Q4 Earnings Snapshot (Associated Press Finance)
06:00AM	Haemonetics 4th Quarter and Fiscal Year 2024 Earnings Release Available on Investor Relations Website (PR Newswire)
May-08-24 09:15PM	Insider Sale at Haemonetics Corp (HAE): EVP, Chief Technology Officer Anila Lingamneni Sells ... (GuruFocus.com)
May-06-24 09:16AM	Exploring Analyst Estimates for Haemonetics (HAE) Q4 Earnings, Beyond Revenue and EPS (Zacks)
May-01-24 11:51AM	Haemonetics (HAE) Banks on Plasma Arm Growth Amid Rising Costs (Zacks)
Apr-12-24 09:03AM	Why You Should Add Haemonetics (HAE) to Your Portfolio Now (Zacks)
Apr-10-24 04:58PM	Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2024 Results: May 9, 2024 (PR Newswire)
Apr-08-24 03:20PM	Royce Investment Partners Commentary: What Will Fuel Small-Cap Returns? (GuruFocus.com)
Apr-05-24 09:48AM	Haemonetics' (HAE) New TEG 6s Cartridge Gets FDA Approval (Zacks)

Haemonetics Corp. engages in the development and distribution of hematology products and solutions. It operates through the following segments: Plasma, Blood Center, and Hospital. The Plasma segment offers automated plasma collection and donor management software systems. The Blood Center segment provides solutions for donor collection centers' ability to acquire blood, filter blood, and separate blood components. The Hospital segment includes hemostasis management, cell salvage, and transfusion management services that help decision makers in hospitals optimize blood acquisition, storage, and usage in critical settings. The company was founded by Allen Latham, Jr. in 1971 and is headquartered in Boston, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Lingamneni Anila	Former Officer	Nov 11 '24	Proposed Sale	90.68	6,238	565,692		Nov 12 11:26 AM
Strong Stewart W	President, Global Hospital	Jul 26 '24	Sale	91.15	4,312	393,039	18,196	Jul 29 05:03 PM
Strong Stewart W	Officer	Jul 26 '24	Proposed Sale	91.15	4,312	393,039		Jul 26 09:47 AM
Lingamneni Anila	EVP, Chief Technology Officer	Jul 11 '24	Sale	90.00	2,136	192,240	21,410	Jul 15 04:27 PM
Lingamneni Anila	EVP, Chief Technology Officer	Jul 12 '24	Sale	90.00	79	7,110	21,331	Jul 15 04:27 PM
Simon, Christopher	President & CEO	Jun 06 '24	Option Exercise	41.64	104,516	4,352,046	433,877	Jun 07 04:15 PM
Basil Michelle L	EVP and General Counsel	May 29 '24	Sale	88.08	12,990	1,144,208	31,257	May 29 05:38 PM
Strong Stewart W	President, Global Hospital	May 29 '24	Sale	87.53	8,857	775,253	18,196	May 29 05:27 PM
Strong Stewart W	President, Global Hospital	May 20 '24	Option Exercise	56.57	2,241	126,773	20,437	May 21 06:01 PM
Strong Stewart W	President, Global Hospital	May 20 '24	Sale	95.11	686	65,245	18,196	May 21 06:01 PM
Llorens Josep	EVP, Global Manufacturing	May 20 '24	Sale	95.08	987	93,844	21,310	May 21 05:52 PM
Llorens Josep	EVP, Global Manufacturing	May 17 '24	Sale	94.82	822	77,942	16,350	May 21 05:52 PM
Basil Michelle L	EVP and General Counsel	May 20 '24	Sale	95.08	1,604	152,508	31,257	May 21 05:46 PM
Basil Michelle L	EVP and General Counsel	May 17 '24	Sale	95.00	1,073	101,935	29,352	May 21 05:46 PM
Strong Stewart W	President, Global Hospital	May 16 '24	Option Exercise	57.60	2,410	138,816	18,018	May 17 05:11 PM
Strong Stewart W	President, Global Hospital	May 16 '24	Sale	96.04	733	70,397	15,608	May 17 05:11 PM
Basil Michelle L	EVP and General Counsel	May 16 '24	Sale	96.14	985	94,698	30,425	May 17 05:02 PM
Llorens Josep	EVP, Global Manufacturing	May 16 '24	Sale	96.14	770	74,028	17,172	May 17 04:55 PM
Lingamneni Anila	EVP, Chief Technology Officer	May 06 '24	Sale	95.00	2,305	218,975	12,295	May 08 04:21 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

HAE

Haemonetics Corp

Upgrade your FINVIZ experience